Evidence map›Paper›PMID 41114353›Full record

ArticleFrontiers in oncology2025

Case report of squamous cell carcinoma secondary to recurrent anal fistula.

Qin-Bing Zhu, Jing Zhang, Chen-Yuan Liu, Hui Ye, Shi-Ping Huang, Ya-Hong Xue

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qin-Bing Zhu *Graduate School, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Jing Zhang *Graduate School, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Chen-Yuan LiuGraduate School, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Hui YeAnorectal, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Shi-Ping HuangAnorectal, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Ya-Hong XueAnorectal, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anal fistula is a common benign perianal condition, and its malignant transformation, particularly into squamous cell carcinoma, is rare and often associated with comorbidities such as Crohn's disease and HIV infection. This article reports the case of a 66-year-old male with a history of recurrent anal fistula spanning more than 10 years who underwent 3 surgical treatments. Pathological findings from the first two surgeries showed no malignant lesions, while the third confirmed moderately to poorly differentiated squamous cell carcinoma. The patient had a history of lymphoma and small bowel resection; HIV infection was excluded upon admission. Carcinoembryonic antigen and cytokeratin 19 fragment levels were mildly elevated, and imaging revealed a high complex anal fistula. The diagnosis was ultimately confirmed by pathological biopsy. We propose that malignant transformation may be linked to chronic inflammatory stimulation, reduced immune function, and prior abdominal surgery. Diagnosis depends on pathological confirmation, and the use of multiple imaging modalities can improve diagnostic accuracy. The uniqueness of this case lies in the non-continuous recurrence of the anal fistula, offering a new perspective on the clinical characteristics of anal fistula carcinogenesis.

Indexed as

anal fistulacasemalignant transformationsecondarysquamous cell carcinoma

Identifiers

PMID41114353
PMCPMC12527834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.